NCT00258713 - A 36-Week Extension to Protocol ISA04-03 | Biotech Hunter

Enrollment

309

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions

Psoriasis

Interventions

DRUG

voclosporin

voclosporin 0.2, 0.3, or 0.4 mg/kg BID

Trial Locations (29)

T2S 3B3

Isotechnika Investigational Site, Calgary

T5J 3S9

Isotechnika Investigational Site, Edmonton

V5Z 3Y1

Isotechnika Investigational Site, Vancouver

V5Z 4E8

Isotechnika Investigational Site, Vancouver

R3C 0N2

Isotechnika Investigational Site, Winnipeg

E1C 8X3

Isotechnika Investigational Site, Moncton

A1B 3E1

Isotechnika Investigational Site, St. John's

A1B 4F8

Isotechnika Investigational Site, St. John's

B3H 1Z4

Isotechnika Investigational Site, Halifax

L4M 6L2

Isotechnika Investigational Site, Barrie

L8N 1V6

Isotechnika Investigational Site, Hamilton

N5X 2P1

Isotechnika Investigational Site, London

N6A 3H7

Isotechnika Investigational Site, London

L4K 5V2

Isotechnika Investigational Site, Maple

L3P 1A8

Isotechnika Investigational Site, Markham

L3Y 6P5

Isotechnika Investigational Site, Newmarket

P1B 3Z7

Isotechnika Investigational Site, North Bay

L6K 1E1

Isotechnika Investigational Site, Oakville

L1H 1B9

Isotechnika Investigational Site, Oshawa

N2J 1C4

Isotechnika Investigational Site, Waterloo

N8W 1E6

Isotechnika Investigational Site, Windsor

N8W 5L7

Isotechnika Investigational Site, Windsor

H7G 2C6

Isotechnika Investigational Site, Laval

H2K 4L5

Isotechnika Investigational Site, Montreal

H3G 1C6

Isotechnika Investigational Site, Montreal

H3H 1V4

Isotechnika Investigational Site, Montreal

H9R 4S3

Isotechnika Investigational Site, Pointe-Claire

G1V 4X7

Isotechnika Investigational Site, Saint Foy

J1J 2B8

Isotechnika Investigational Site, Sherbrooke